[go: up one dir, main page]

WO2019202611A1 - Procédé amélioré pour la synthèse de l'ivabradine ou de ses sels pharmaceutiquement acceptables - Google Patents

Procédé amélioré pour la synthèse de l'ivabradine ou de ses sels pharmaceutiquement acceptables Download PDF

Info

Publication number
WO2019202611A1
WO2019202611A1 PCT/IN2019/050316 IN2019050316W WO2019202611A1 WO 2019202611 A1 WO2019202611 A1 WO 2019202611A1 IN 2019050316 W IN2019050316 W IN 2019050316W WO 2019202611 A1 WO2019202611 A1 WO 2019202611A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
dimethoxy
dihydro
formula
ivabradine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2019/050316
Other languages
English (en)
Inventor
Venkateswara Rao Nandepu
Durga Prasad BOPPANA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metrochem Api Pvt
Original Assignee
Metrochem Api Pvt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metrochem Api Pvt filed Critical Metrochem Api Pvt
Publication of WO2019202611A1 publication Critical patent/WO2019202611A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines

Definitions

  • Ivabradine is a representative of this class of compounds and is depicted below as Formula I.
  • the chemical name is 3-(3- ⁇ [((7S)-3,4-Dimethoxybicyclo[4.2.0]octa- l,3,5-trien-7yl)methyl] methyl amino ⁇ propyl)-l,3,4,5-tetrahydro-7,8-dimethoxy- 2H-3 -benzazepin-2-one .
  • the invention provides a process for preparation of Ivabradine of formula I or its pharmaceutical salt by condensation of the formula II with formula III.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé amélioré pour la préparation de l'ivabradine ou de ses sels pharmaceutiquement acceptables. L'invention concerne plus particulièrement la synthèse d'intermédiaires clés à savoir, le chlorhydrate de (S)-N-[(4,5-diméthoxybenzocydobut-l-yl)-méthyl]-N- (méthyl)amine de formule-II et le 3-(3-Iodopropyl)-7,8-diméthoxy-1,3-dihydro-2H-3-benzapin-2-one de formule-III, et leur utilisation dans la synthèse industrielle de l'ivabradine et de ses sels pharmaceutiquement acceptables.
PCT/IN2019/050316 2018-04-21 2019-04-18 Procédé amélioré pour la synthèse de l'ivabradine ou de ses sels pharmaceutiquement acceptables Ceased WO2019202611A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201841015175 2018-04-21
IN201841015175 2018-04-21

Publications (1)

Publication Number Publication Date
WO2019202611A1 true WO2019202611A1 (fr) 2019-10-24

Family

ID=68240006

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2019/050316 Ceased WO2019202611A1 (fr) 2018-04-21 2019-04-18 Procédé amélioré pour la synthèse de l'ivabradine ou de ses sels pharmaceutiquement acceptables

Country Status (1)

Country Link
WO (1) WO2019202611A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014102827A1 (fr) * 2012-12-28 2014-07-03 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Procédé de préparation d'ivabradine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014102827A1 (fr) * 2012-12-28 2014-07-03 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Procédé de préparation d'ivabradine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANIL C. MALI ET AL.: "Practical and green process for the synthesis of Ivabradine hydrochloride through an efficient control of process impurities", CURRENT GREEN CHEMISTRY, vol. 4, no. 3, 31 December 2017 (2017-12-31), pages 151 - 160 *

Similar Documents

Publication Publication Date Title
US8212026B2 (en) Process for the preparation of ivabradine hydrochloride and polymorph thereof
JP5661773B2 (ja) インドリン誘導体の調製方法およびこれらの中間体
EP2768806B1 (fr) Procédé de préparation de silodosine
KR20200068663A (ko) 리피테그라스트의 신규 제조 방법
JP2818763B2 (ja) N−(ヒドロキシ)アラルキルフェニルエタノールアミン類のo−アルキル化された化合物
CA2773064C (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
KR20180129854A (ko) 부토르파놀 타르트레이트의 개선된 제조 방법
CA2767893C (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
JPH0314548A (ja) 2―アミノ―7―ヒドロキシテトラリンカルボキシアルキルエーテル類およびその製造方法
WO2019239202A1 (fr) Nouvelle synthèse améliorée de médicament antipsychotique
WO2019202611A1 (fr) Procédé amélioré pour la synthèse de l'ivabradine ou de ses sels pharmaceutiquement acceptables
JP4508528B2 (ja) α−アミノ置換カルボン酸アミドの製造方法
CN101687859A (zh) 阿呋唑嗪及其盐的制备工艺
JP4374088B2 (ja) 新規な4,4−ジフルオロベンゾアゼピンケタール誘導体、およびそれを経由する4,4−ジフルオロベンゾアゼピン−5−オン誘導体の製造方法
US7446227B2 (en) Process for preparation of 5H-dibenzo[a,d] cycloheptene derivatives
CN1829696A (zh) 苯那普利的制备方法
EP1568689A1 (fr) Procédé de préparation du dérivé 2-oxoindole, Ropinirole
WO2017138017A1 (fr) Procédé de préparation d'un dérivé de benzazépine-2-one
HK1183295B (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1183488B (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
KR20050055157A (ko) 키랄 알킬화 반응을 이용한 펩티드의 새로운 제조 방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19788699

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19788699

Country of ref document: EP

Kind code of ref document: A1